Research output per year
Research output per year
Fingerprint
Dive into the research topics where Petra Huber-Cantonati is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Prenylated Chalcones From Roots of Kidney Vetch (Anthyllis vulneraria L.) With Antiproliferative Activity
Lorenz, P., Conrad, J., Klaiber, I., Mailaender, L. K., Gazafroudi, K. N., Stintzing, F. C., Kammerer, D. R., Ablinger, C. & Huber-Cantonati, P. (Last author), 1 Mar 2025, In: CHEMISTRY & BIODIVERSITY. 15 p.Research output: Contribution to journal › Original Article › peer-review
-
Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy-A State-of-the-Art Review
Rose, O. (First author), Croonenberg, T., Clemens, S. (Co-author), Hinteregger, T., Eppacher, S., Huber-Cantonati, P. (Co-author), Garcia-Miralles, M., Liuni, R. (Co-author) & Dossena, S. (Last author), 21 Dec 2024, In: Antioxidants. 13, 12, 31 p., 1578.Research output: Contribution to journal › Review article › peer-review
Open Access -
Impact of 2-hydroxypropyl-β-cyclodextrin inclusion complex formation on dopamine receptor-ligand interaction - A case study
Zell, L. (First author), Hofer, T. S., Schubert, M., Popoff, A. (Co-author), Hoell, A., Marschhofer, M., Huber-Cantonati, P. (Co-author), Temml, V. (Co-author) & Schuster, D. (Last author), Aug 2024, In: BIOCHEMICAL PHARMACOLOGY . 226, 13 p., 116340.Research output: Contribution to journal › Original Article › peer-review
Open Access -
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancer
Ablinger, C., Neureiter, D. (Co-author), Mähr, T., Mayr, C. (Co-author), Kiesslich, T. (Co-author), Maeding, N. (Co-author), Valenta, I., Ardelt, M. (Co-author), Wilhelm, F., Neureiter, E., Ritter, M. (Co-author), Pachmayr, J. (Co-author) & Huber-Cantonati, P. (Last author), 31 Dec 2024, In: CANCER BIOLOGY & THERAPY. 25, 1, p. 2439057 14 p., 2439057.Research output: Contribution to journal › Original Article › peer-review
Open Access -
Benzylated dihydrochalcones as a novel therapeutic approach for the treatment of hepatocellular and thyroid carcinoma
Huber-Cantonati, P., Temml, V., Meier, L., Schwitzer, F., Mähr, T., Viault, G., Ghidini, A., Helesbeux, J., Schuster, D. & Pachmayr, J., 2023, In: PLANTA MEDICA. 89, 14, p. 1414 1 p.Research output: Contribution to journal › Abstract (Journal) › peer-review
Activities
-
DIHYDROCHALCONES: EXPLORING NATURAL COMPOUND DERIVATIVES FOR CANCER THERAPY
Huber-Cantonati, P. (Keynote speaker)
2024Activity: Talk or presentation › Oral presentation
-
Dihydrochalcones: Harnessing Nature's Palette in Cancer Research
Huber-Cantonati, P. (Keynote speaker)
2024Activity: Talk or presentation › Oral presentation
-
HMPPA Symposium - Next Generation in Pharmacognosy
Huber-Cantonati, P. (Chair) & Temml, V. (Chair)
11 May 2023 → 12 May 2023Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA
-
71st International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research
Huber-Cantonati, P. (Organiser)
2023 → …Activity: Participating in or organising an event › Participating in a conference, workshop, ...
-
Benzylated dihydrochalcones – new therapeutic option in hepatocellular and breast carcinoma
Huber-Cantonati, P. (Invited speaker)
2022Activity: Talk or presentation › Oral presentation